2004 Annual Meeting | Clinical Epilepsy I

Date Monday 04/26/04

Time 09:00 AM - 12:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Gregory K. Bergey, MD, FAAN

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Upon completion:
Participants should have an understanding of the characteristics of complex partial seizures; when to initiate AED therapy in their patients with epilepsy and which patients may be candidates to safely medicate; approaches to the patient with epilepsy who has difficulty controlling seizures; and when to incorporate older and newer therapies.

The American Board of Psychiatry and Neurology has reviewed Clinical Epilepsy I and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:45 AM		Complex Partial Seizures: The Clinicopathological Spectrum Gregory K. Bergey, MD, FAAN
09:45 AM - 10:30 AM		When to Start and Stop Antiepileptic Medications Joseph I. Sirven, MD, FAAN
10:30 AM - 10:45 AM		Questions and Answers
10:45 AM - 11:00 AM		Break
11:00 AM - 11:45 AM		Antiepileptic Drug Selection in the Patient with Difficult to Control Seizures Michael D. Privitera, MD, FAAN
11:45 AM - 12:30 PM		Driving and Epilepsy Gregory Krauss, MD
12:30 PM - 12:45 PM		Discussion

Faculty Disclosures
Gregory K. Bergey, MD, FAAN	Dr. Bergey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics.
Michael D. Privitera, MD, FAAN	Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK life science. Dr. Privitera has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK life science. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Privitera has received research support from Neurelis. The institution of Dr. Privitera has received research support from Biohaven. Dr. Privitera has received research support from Neurava.
Gregory Krauss, MD	Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Joseph I. Sirven, MD, FAAN	Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
	No disclosure on file

��ɫ��

��ɫ��